Clinical Trial Update: A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation [Phase 3]

View source ↗

Summary

A Phase 3 reader study evaluating the accuracy and reliability of Flortaucipir F-18 PET scan interpretation for Alzheimer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Flortaucipir F-18 (flortaucipir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-08-11